In the News

413 News Items found
Dr. Michael Overholtzer speaks to students.
Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.
Colorful illustration of people overlaid on a world map
Finding
A new study reports a possible way to quantify how efficient the immune system is at detecting cancer, and therefore how likely it is that a person will respond to immunotherapy.
Radiation oncologist and CyberKnife expert Abraham Wu
Ask the Expert
Why Am I Hearing So Much About CyberKnife?
CyberKnife is a brand name for one of several available stereotactic radiosurgery devices that deliver radiation with linear accelerators. MSK uses a similar device, made by a company called Varian, that destroys tumors with extremely precise, very intense doses of radiation.
MSK medical oncologist Komal Jhaveri
Article
Read about a new FDA-approved treatment for people with some ER+, HER2- advanced breast cancers.
Reicy Bobadilla stands in front of a window with the MSK logo on it
A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.
Dr. Robert Motzer speaks to a patient
MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.
Two Fred’s Team runners wearing orange shirts in a crowd
Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
A gloved hand holds a petri dish
A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
A researcher working in an MSK lab
MSK Research Highlights, December 16, 2025
New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.